Results 81 to 90 of about 2,470,912 (293)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Advances in Electrical and Electronic Engineering, 2013 The paper deals with the problem of determination of error probability of cryptography and safety codes used within the safety-related railway applications with increasing safety integrity level (SIL).
Maria Franekova +2 more
doaj +1 more source
An Error Probability Approach to MIMO Wiretap Channels
, 2013 We consider MIMO (Multiple Input Multiple Output) wiretap channels, where a legitimate transmitter Alice is communicating with a legitimate receiver Bob in the presence of an eavesdropper Eve, and communication is done via MIMO channels.
Belfiore, Jean-Claude +1 more
core +1 more source
Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni +19 more
wiley +1 more source
Error Probability Bounds for Balanced Binary Relay Trees
, 2011 We study the detection error probability associated with a balanced binary relay tree, where the leaves of the tree correspond to $N$ identical and independent detectors.
Chong, Edwin K. P. +4 more
core +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Circular
IEEE Access, 2019 This paper proposes M-ary circular θ-quadrature amplitude modulation (CTQAM) for M = 2l, l ≥ 4, which is constructed by rearrangement of the signal points based on θ-QAM.
Seongjin Ahn, Dongweon Yoon
doaj +1 more source
MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru +13 more
wiley +1 more source
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source
Error Probability Mitigation in Quantum Reading Using Classical Codes. [PDF]
Entropy (Basel), 2021 Fernandes Pereira FR, Mancini S.
europepmc +1 more source